Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Liposarcoma 1Leiomyosarcoma 1Carcinoma, Renal Cell 1

Interventions

Radiotherapy 3Radiation 3Doxorubicin 3pazopanib 2Nivolumab 2talimogene laherparepvec 1sotigalimab 1rucaparib 1ribociclib 1olaparib 1futibatinib 1durvalumab 1cediranib 1cabozantinib 1Temozolomide 1Specimen Handling 1PM 01183 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Biopsy 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leiomyosarcoma × sotigalimab × Clear all
NCT03719430 2025-04-29

APX005M and Doxorubicin in Advanced Sarcoma

Columbia University

Phase 2 Active not recruiting
27 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡